This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 September 2026.
All research outputs
#3,786,894
of 26,775,256 outputs
Outputs from Cancer Biotherapy & Radiopharmaceuticals
#31
of 749 outputs
Outputs of similar age
#66,878
of 344,857 outputs
Outputs of similar age from Cancer Biotherapy & Radiopharmaceuticals
#2
of 7 outputs
Altmetric has tracked 26,775,256 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 749 research outputs from this source. They receive a mean Attention Score of 3.6. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,857 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.
